Navigation Links
Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma
Date:6/30/2008

- Phase II Trial Shows Increase in Mature Dendritic Cells -

WAYNE, N.J., June 30 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals today confirmed that results of a Phase II trial were published in the July 1 edition of the Journal of Clinical Oncology. The study showed that Leukine(R) (sargramostim) demonstrated a median overall survival of 65 months and increased mature dendritic cells in high-risk melanoma patients. Dendritic cells are special antigen-presenting cells that help the immune system recognize cancer cells and are the most effective antigen-presenting cells known. Study authors concluded that this increase in dendritic cell counts may also correlate with delayed recurrence of disease.

"These data provide early signals that Leukine may offer clinical benefit in this patient group by increasing and differentiating dendritic cells and perhaps by benefiting patients who have lowered baseline levels of dendritic cells," said Dr. Adil Daud, first author of the study and Associate Professor, Director, Clinical Research, University of California, San Francisco Melanoma Center. "Patients who experienced an increase of dendritic cells were more likely to demonstrate delayed disease recurrence."

In this Phase II prospective trial, 42 patients with resected high-risk (Stage IIIB, IIIC or IV) melanoma were treated with Leukine (125 mcg/m2/day for 14 consecutive days followed by 14 days of no treatment). This regimen was repeated for 13 cycles unless patients had unacceptable toxicity or showed evidence of disease recurrence. Patients had no evidence of disease at the start of the trial as measured by imaging. Patients underwent restaging every four months. The most common adverse events found in the study were injection site reactions (88 percent), pain (61 percent), arthralgia/myalgia (61 percent), fatigue (61 percent), flu-like symptoms (39 percent) and insomnia (27 percent).

Of the 42 enrolled patients, 39 were av
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)
2. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
3. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
4. Biopure Phase III Orthopedic Trial Results Published in Journal of Trauma
5. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
6. Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening
7. Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
8. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
9. Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology
10. Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
11. Multi Merci Trial Results Published in Peer Reviewed Journal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... May 1, 2015   Heska Corporation (NASDAQ: ... a provider of advanced veterinary diagnostic and other specialty ... Executive Chair, will present at the 16th Annual B. Riley ... 13, 2015. The conference will be held May 12-14, 2015 ... Heska management will be available during the day on ...
(Date:5/1/2015)... , May 1, 2015 At the ... 2-6 in Washington D.C. , Elekta ... solution that enables clinicians to leverage the enormous amount ... radiosurgery treatments conducted each year – to advance clinical ... Knife Registry is a cloud-based solution that allows practitioners ...
(Date:5/1/2015)... 1, 2015 Braeburn Pharmaceuticals announced ... therapeutic focus beyond addiction and pain to ... Braeburn has acquired an implantable, six-month formulation ... for treatment of schizophrenia from Endo Pharmaceuticals. ... rights to other potential applications of the ...
Breaking Medicine Technology:Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 2Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 4
... SAN DIEGO, Oct. 28 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... 30, 2009. For the third quarter of 2009, the Company reported ... with a net loss of $17.7 million, or $0.46 per share, ... September 30, 2009, the Company reported a net loss of $43.1 ...
... BATESVILLE, Ind., Oct. 28 Hill-Rom Holdings, Inc. (NYSE: ... and 2010 financial guidance on Wednesday, November 11, 2009. ... morning on Thursday, November 12, 2009 at 7:30 a.m. EST. ... Quarter Earnings and 2010 Financial Guidance release will be issued ...
Cached Medicine Technology:Neurocrine Biosciences Reports Third Quarter 2009 Results 2Neurocrine Biosciences Reports Third Quarter 2009 Results 3Neurocrine Biosciences Reports Third Quarter 2009 Results 4Neurocrine Biosciences Reports Third Quarter 2009 Results 5Neurocrine Biosciences Reports Third Quarter 2009 Results 6Neurocrine Biosciences Reports Third Quarter 2009 Results 7Neurocrine Biosciences Reports Third Quarter 2009 Results 8Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Fourth Quarter Earnings and 2010 Financial Guidance Webcast 2
(Date:5/1/2015)... 2015 It’s raining bills on Capitol Hill ... to expand federal support for telemedicine. , “Such ... been working with Congress,” said Jonathan Linkous, CEO of the ... nation is poised to embrace the use of telecommunications in ... in fulfilling ATA’s mission to improve quality, access, equity and ...
(Date:5/1/2015)... May 01, 2015 Ernst & Young ... Joshua Rosenthal, Co-Founder & CSO, and Burak Sezen, Co-Founder ... the EY Entrepreneur Of The Year® 2015 Awards ... Young is a global leader in assurance, tax, ... be one of the top audit companies in the ...
(Date:5/1/2015)... The Quail Creek Relay for Life Team raised over $89,000 ... Creek Relay team has raised almost $860,000. Quail Creek ... their biggest event, January’s Dinner and Auction; an annual Putting ... Relay for Life team was established to honor a member’s ... “I was hooked when I learned how the money raised ...
(Date:5/1/2015)... As the sale of legal, recreational cannabis ... people in the industry are looking back with some ... annual report by the ArcView Group , the ... reached nearly $3 billion in combined wholesale and retail ... combined with the ongoing economic recovery, has led to ...
(Date:5/1/2015)... The frozen yogurt chain sweetFrog Enterprises is ... and the Myrtle Beach Pellicans (SC). As part of ... offer fans discounts at local sweetFrog locations. , “We ... Luke Shook, co-owner of the Hickory sweetFrog. “Sponsoring ... forward to enjoying the games and the great taste ...
Breaking Medicine News(10 mins):Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2Health News:Quail Creek Country Club’s Relay for Life Team Raised Over $89,000 for American Cancer Society 2Health News:Colorado cannabis dispensary owner credits employees for successful “420” retail sales figures 2Health News:Colorado cannabis dispensary owner credits employees for successful “420” retail sales figures 3Health News:sweetFrog Announces Minor League Baseball Partnerships 2
... strategy to hunt for human viruses described in this ... team who found the cause of Kaposis sarcoma has ... rare but deadly skin cancer called Merkel cell carcinoma. ... researchers, Huichen Feng, Ph.D., Masahiro Shuda, Ph.D., Yuan Chang, ...
... better treatments, researchers say , , THURSDAY, Jan. 17 (HealthDay News) ... twins, scientists say they,re gaining new insight into how some ... The researchers report in a new study that both twins ... shared cells that mutated and became precancerous. In one of ...
... Bionic Woman use bionic eyes to zoom in on far-off ... or create virtual crosshairs. Off the screen, virtual displays have ... help vision-impaired people, holographic driving control panels and even as ... , The device to make this happen may be familiar. ...
... ATLANTA, Jan. 17 Fundraising for two of,Atlanta,s ... Atlanta Mayor Shirley Franklin and Wachovia,s Atlanta ... to the Atlanta BeltLine,Partnership and the Center for ... Foundation. The gifts will go toward each initiative,s,capital ...
... FOREST, Ill., Jan. 17 Hospira, Inc.,(NYSE: HSP ... it will host a conference call to discuss its ... Thursday, Feb. 28, 2008,at 8 a.m. Central Time., ... results,earlier that morning, before the U.S. stock market open ...
... officials are constantly in battle mode against illness ... to fight these deadly foes they need more ... Researchers from the Regenstrief Institute and the Indiana ... electronic medical laboratory reporting (ELR) improves both the ...
Cached Medicine News:Health News:Newly discovered virus linked to deadly skin cancer 2Health News:Newly discovered virus linked to deadly skin cancer 3Health News:Newly discovered virus linked to deadly skin cancer 4Health News:Study Gets Closer to Origins of Leukemia 2Health News:Contact lenses with circuits, lights a possible platform for superhuman vision 2Health News:Contact lenses with circuits, lights a possible platform for superhuman vision 3Health News:Wachovia Foundation Announces $1 Million Each for Atlanta BeltLine Partnership, Center for Civil and Human Rights 2Health News:Wachovia Foundation Announces $1 Million Each for Atlanta BeltLine Partnership, Center for Civil and Human Rights 3Health News:Battling potential disease outbreaks online 2
... 3100 is a small, lightweight ... worn comfortably on the patients ... activities and for overnight studies, ... WristOx is intended to give ...
... 5500TM is the worlds first spot ... and heart rate to use reflectance ... uses SPO Medicals patented technology to ... more usable for many patients and ...
All-in-One Fingertip Oximeter...
The reliable and easy-to-use 3900/P pulse oximeter is now more advanced - featuring TruTrak+ technology, the proprietary clinical motion algorithm from Datex+-Ohmeda....
Medicine Products: